Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases

Advances in Neurology 2024

04 November 2024 | Virtual Webinar

VJNeurology is excited to bring you presentation summaries and panel discussions from our webinar on Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases.

Chaired by Prof. Charlotte Teunissen, Amsterdam UMC, Netherlands

Co-moderated by Dr Nicholas Ashton, University of Gothenburg, Sweden &
Prof. Malú G. Tansey, University of Florida, USA

Please note this webinar is intended for healthcare professionals, allied health professionals & researchers only.

Session 1: Utility of blood and fluid biomarkers for Alzheimer’s disease Session 2: Guidelines and recommendations for dementia diagnosis and staging Session 3: Additional advances in dementia detection

Session 1: Utility of blood and fluid biomarkers for Alzheimer’s disease

Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology

Nicholas Ashton University of Gothenburg

Plasma protein profiling reveals novel and specific biomarkers reflecting the multifactorial nature of clinical stages in Alzheimer’s disease

Giovanni Bellomo University of Perugia

Novel body fluid biomarkers specific for different dementias. A strategy towards clinical use

Charlotte Teunissen Amsterdam UMC

Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset

Michael Bartl University of Göttingen

Session 1: panel discussion

Session 2: Guidelines and recommendations for dementia diagnosis and staging

Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup

Clifford R. Jack Jr Mayo clinic

European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders

Federico Massa University of Genoa

Acceptable performance of blood biomarker tests of amyloid pathology – recommendations from the global CEO initiative on Alzheimer’s disease

Suzanne Schindler Washington University School of Medicine St. Louis

Session 2: panel discussion

Session 3: Additional advances in dementia detection

Validation of Icobrain Aria – An AI-based software tool for automated detection and quantification of amyloid-related imaging abnormalities 

Dirk Smeets icometrix

A novel immunoassay to measure CSF DOPA-decarboxylase, a promising biomarker candidate for dementia with Lewy bodies

Katharina Bolsewig Amsterdam UMC

Session 3: panel discussion

Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases was supported by Olink, part of Thermo Fisher Scientific. The sponsor had no influence over the production of content.

Silver Sponsor

Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases

Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases

Cookie settings